Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maura L Gillison
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- the James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
- Nyu Langone Hospital - Long Island
Mineola, New York, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Highland Hospital
Rochester, New York, United States
- University of Rochester
Rochester, New York, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, United States
- Sanford Usd Medical Center - Sioux Falls
Sioux Falls, South Dakota, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Inova Schar Cancer Institute
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2021
- Primary completion
- 7 Dec 2025
- Completion
- 15 Dec 2026
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 21
- Registry id
- NCT04533750
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.